Bioresorbable Polymer Medical Devices Market Report 2026
Global Outlook – By Product Type (Bioresorbable Implants, Bioresorbable Surgical Sutures, Bioresorbable Vascular Stents, Bioresorbable Orthopedic Fixation Products, Bioresorbable Tissue Engineering Scaffolds, Bioresorbable Drug Delivery Systems, Bioresorbable Dental Implants, Other Bioresorbable Medical Devices), By Polymer Material Type (Polylactic Acid, Polyglycolic Acid, Polycaprolactone, Polydioxanone, Polylactic Acid And Polyglycolic Acid Copolymers, Polyhydroxyalkanoates, Polysaccharide Based Polymers, Protein Based Polymers, Other Bioresorbable Polymers), By Distribution Channel (Direct Sales, Third-Party Medical Distributors, Online Procurement Platforms), By Application (Cardiovascular Applications, Orthopedic Applications, Dental Applications, Wound Care Applications, Regenerative Medicine Applications, Drug Delivery Applications, General Surgery Applications, Other Medical Applications), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutes, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Bioresorbable Polymer Medical Devices Market Overview
• Bioresorbable Polymer Medical Devices market size has reached to $1.64 billion in 2025 • Expected to grow to $2.28 billion in 2030 at a compound annual growth rate (CAGR) of 6.9% • Growth Driver: Increasing Preference For Minimally Invasive Surgical Procedures Is Driving The Market Growth Due To Rising Adoption Of Bioabsorbable Implants • Market Trend: Innovation In Fully Resorbable Polymer Implants Expands Orthopedic Treatment Options • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Bioresorbable Polymer Medical Devices Market?
Bioresorbable polymer medical devices refer to specialized therapeutic implants, such as vascular stents or orthopedic screws, manufactured from materials like polylactic acid (PLA) or polyglycolic acid (PGA) that are designed to safely degrade and be naturally absorbed by the body over time. This technology eliminates the need for secondary surgical procedures to remove hardware once tissue healing is complete, significantly improving patient comfort and reducing long-term complication risks. The main product types of bioresorbable polymer medical devices include bioresorbable implants, bioresorbable surgical sutures, bioresorbable vascular stents, bioresorbable orthopedic fixation products, bioresorbable tissue engineering scaffolds, bioresorbable drug delivery systems, bioresorbable dental implants, and other bioresorbable medical devices. Bioresorbable implants refer to medical devices designed to provide temporary structural support or therapeutic functions and gradually break down and are absorbed by the body after fulfilling their intended purpose. These devices are manufactured using polylactic acid, polyglycolic acid, polycaprolactone, polydioxanone, polylactic acid and polyglycolic acid copolymers, polyhydroxyalkanoates, polysaccharide based polymers, protein based polymers, and other bioresorbable polymers and are distributed through direct sales, third-party medical distributors, and online procurement platforms. The various applications involved are cardiovascular applications, orthopedic applications, dental applications, wound care applications, regenerative medicine applications, drug delivery applications, general surgery applications, and others, and they are utilized by end users including hospitals, ambulatory surgical centers, specialty clinics, research and academic institutes, and others.
What Is The Bioresorbable Polymer Medical Devices Market Size and Share 2026?
The bioresorbable polymer medical devices market size has grown strongly in recent years. It will grow from $1.64 billion in 2025 to $1.75 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing demand for minimally invasive procedures, rising preference for temporary implant solutions, growing adoption of bioresorbable vascular devices, increasing need to reduce secondary implant removal surgeries, expanding use of biodegradable polymers in medical devices.What Is The Bioresorbable Polymer Medical Devices Market Growth Forecast?
The bioresorbable polymer medical devices market size is expected to see strong growth in the next few years. It will grow to $2.28 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing demand for patient-specific implants, rising adoption of resorbable orthopedic fixation devices, growing need for controlled implant degradation, expanding clinical applications of bioresorbable polymers, increasing preference for long-term biocompatible implant solutions. Major trends in the forecast period include patient-specific bioresorbable implant design, controlled polymer degradation, expansion of bioresorbable vascular stents, development of next-generation biodegradable polymers, increasing use of resorbable orthopedic fixation devices.
Global Bioresorbable Polymer Medical Devices Market Segmentation
1) By Product Type: Bioresorbable Implants, Bioresorbable Surgical Sutures, Bioresorbable Vascular Stents, Bioresorbable Orthopedic Fixation Products, Bioresorbable Tissue Engineering Scaffolds, Bioresorbable Drug Delivery Systems, Bioresorbable Dental Implants, Other Bioresorbable Medical Devices 2) By Polymer Material Type: Polylactic Acid, Polyglycolic Acid, Polycaprolactone, Polydioxanone, Polylactic Acid And Polyglycolic Acid Copolymers, Polyhydroxyalkanoates, Polysaccharide Based Polymers, Protein Based Polymers, Other Bioresorbable Polymers 3) By Distribution Channel: Direct Sales, Third-Party Medical Distributors, Online Procurement Platforms 4) By Application: Cardiovascular Applications, Orthopedic Applications, Dental Applications, Wound Care Applications, Regenerative Medicine Applications, Drug Delivery Applications, General Surgery Applications, Other Medical Applications 5) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research And Academic Institutes, Other End Users Subsegments: 1) By Bioresorbable Implants: Cardiovascular Implants, Orthopedic Implants, Craniomaxillofacial Implants, Soft Tissue Repair Implants, Neurological Implants 2) By Bioresorbable Surgical Sutures: Monofilament Sutures, Braided Sutures, Barbed Sutures, Antibacterial Sutures 3) By Bioresorbable Vascular Stents: Coronary Stents, Peripheral Vascular Stents, Neurovascular Stents 4) By Bioresorbable Orthopedic Fixation Products: Interference Screws, Bone Pins, Bone Plates, Bone Anchors, Intramedullary Nails 5) By Bioresorbable Tissue Engineering Scaffolds: Bone Tissue Scaffolds, Cartilage Tissue Scaffolds, Skin Tissue Scaffolds, Nerve Tissue Scaffolds, Cardiac Tissue Scaffolds 6) By Bioresorbable Drug Delivery Systems: Microspheres, Nanoparticles, Implantable Drug Delivery Devices, Injectable Depot Systems, Drug Eluting Films 7) By Bioresorbable Dental Implants: Dental Membranes, Dental Bone Grafts, Dental Fixation Screws, Dental Tissue Regeneration Matrices 8) By Other Bioresorbable Medical Devices: Wound Closure Devices, Surgical Meshes, Hemostatic Devices, Adhesion Barrier Devices, Ophthalmic ImplantsWhat Is The Driver Of The Bioresorbable Polymer Medical Devices Market?
The increasing preference for minimally invasive surgical procedures is expected to propel the growth of the bioresorbable polymer medical devices market going forward. Minimally invasive surgical procedures are surgical techniques that use small incisions and specialized instruments to perform operations while reducing tissue damage, postoperative pain, and recovery time. Minimally invasive surgical procedures are rising due to increasing patient preference for faster recovery, reduced postoperative pain, shorter hospital stays, and lower risk of complications. Bioresorbable polymer medical devices enable temporary tissue support and naturally degrade after healing, eliminating the need for secondary removal surgeries. For example, in June 2025, according to NHS England, a UK-based government department, around 70,000 robot-assisted minimally invasive surgeries were performed across the NHS in 2023-24. The NHS aims to expand this to 500,000 procedures annually by 2035, with 90% of eligible keyhole surgeries expected to be robot-assisted, reflecting the growing adoption of minimally invasive surgical techniques. Therefore, the increasing preference for minimally invasive surgical procedures is driving the growth of the bioresorbable polymer medical devices industry.Key Players In The Global Bioresorbable Polymer Medical Devices Market
Major companies operating in the bioresorbable polymer medical devices market are Abbott Laboratories, Medtronic plc, Stryker Corporation, Becton Dickinson and Company, Evonik Industries AG, W. L. Gore & Associates Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Terumo Corporation, B. Braun SE, Arkema S.A., Teleflex Incorporated, Kuraray Co. Ltd., Ashland Inc., Corbion N.V., CONMED Corporation, KLS Martin Group SE & Co. KG, Geistlich Pharma AG, Foster Corporation, Putnam Plastics Corporation, GUNZE Limited, Poly-Med Inc., botiss biomaterials GmbH, Inion Oy, Bioretec Ltd., Medprin Biotech GmbH, Acuitive Technologies Inc., REVA Medical Inc., BioCer Entwicklungs-GmbH
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Bioresorbable Polymer Medical Devices Market Trends and Insights
Major companies operating in the bioresorbable polymer medical devices market are focusing on developing advanced products, such as fully resorbable polymer-based implants to improve tissue regeneration, provide temporary mechanical support, and eliminate the need for permanent implants or secondary removal surgeries. Fully resorbable polymer-based implants are medical implants made from polymers that are designed to gradually break down and be absorbed by the body after serving their intended purpose. For instance, in February 2025, Atreon Orthopedics, a US-based orthopedic medical device company, received FDA 510(k) clearance and full market launch of BioCharge Autobiologic Matrix, a fully resorbable synthetic implant designed for rotator cuff repair. The bioresorbable polymer-based scaffold is engineered to reinforce tendon repair while stimulating the body's natural healing response, eliminating the need for permanent implants.What Are Latest Mergers And Acquisitions In The Bioresorbable Polymer Medical Devices Market?
In June 2026, Olympus Corporation, a Japan-based medical technology company, acquired BioProtect Ltd. for $270 million. With this acquisition, Olympus expanded its portfolio of urological and oncology technologies, strengthened its presence in prostate cancer treatment, and gained BioProtect’s biodegradable Balloon Spacer technology, which helps protect healthy tissue during prostate cancer radiation therapy. BioProtect Ltd. is an Israel-based medical device company specializing in the development and manufacture of biodegradable, bioresorbable polymer balloon spacer implants.
Regional Insights
North America was the largest region in the bioresorbable polymer medical devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.Need data for a specific geography? Request Regional Data
What Defines the Bioresorbable Polymer Medical Devices Market?
The bioresorbable polymer medical devices market consists of sales of bioresorbable wound dressings, bioresorbable adhesion barriers, bioresorbable nerve guidance conduits, bioresorbable hemostatic materials and bioresorbable hernia meshes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Bioresorbable Polymer Medical Devices Market Report 2026?
The bioresorbable polymer medical devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioresorbable polymer medical devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Bioresorbable Polymer Medical Devices Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.75 billion |
| Revenue Forecast In 2030 | $2.28 billion |
| Growth Rate | CAGR of 6.9% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Polymer Material Type, Distribution Channel, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Abbott Laboratories, Medtronic plc, Stryker Corporation, Becton Dickinson and Company, Evonik Industries AG, W. L. Gore & Associates Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Terumo Corporation, B. Braun SE, Arkema S.A., Teleflex Incorporated, Kuraray Co. Ltd., Ashland Inc., Corbion N.V., CONMED Corporation, KLS Martin Group SE & Co. KG, Geistlich Pharma AG, Foster Corporation, Putnam Plastics Corporation, GUNZE Limited, Poly-Med Inc., botiss biomaterials GmbH, Inion Oy, Bioretec Ltd., Medprin Biotech GmbH, Acuitive Technologies Inc., REVA Medical Inc., BioCer Entwicklungs-GmbH |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |